News Release

Future Science Group joins the AllTrials campaign

Progressive publisher announces support for campaign to improve clinical trial reporting

Business Announcement

Future Science Group

Future Science Group

image: Future Science Group logo is shown. view more 

Credit: Future Science Group

Future Science Group (FSG) today announced its support of the AllTrials campaign.

The AllTrials campaign aims to improve transparency and reporting of clinical trials. These aims align with those of Future Science Group (FSG), which believes that every trial should be conducted in a transparent and reproducible manner, ensuring that all research, even where negative or inconclusive, is both trustworthy and available to inform medical decision-making.

FSG requires all authors to follow the latest CONSORT and GPP3 guidelines. It is requested that trials are registered in a publicly accessible, free registry that is electronically searchable, open to prospective registrants and managed by a not-for-profit organization. Where trials are unregistered, FSG requires a clear statement and explanation to be included in the article.

"It's great news that FSG has joined AllTrials, and is introducing practical measures to raise awareness and improve the registration practice of researchers, " commented James Cockerill, Campaigns Manager, Sense About Science. "We are calling for every clinical trial--past, present and future--to be registered, and their results reported. It's time for the whole research community to embrace clinical trial transparency, and we welcome efforts from publishers and journals that demonstrate leadership and do what they can to help fix the problem."

"Researchers are sometimes deterred from submitting negative or inconclusive data to journals, as STM publishers have traditionally not prioritized this research for publication," explained Laura Dormer, Senior Manager (Commissioning & Journal Development) at FSG. "We believe that the results of all well-conducted research should be available, and our support for AllTrials is another way of demonstrating our commitment to this."

###

If you are interested in submitting a trial report to a journal published by Future Science Group, please contact us here - info@future-science-group.com.

About Future Science Group

Founded in 2001, Future Science Group (FSG) is a progressive publisher focused on breakthrough medical, biotechnological and scientific research. FSG's portfolio includes two imprints, Future Science and Future Medicine. Both publish eBooks and journals. In addition to this core publishing business, FSG develops specialist eCommunities. Key titles and sites includes Bioanalysis Zone, Epigenomics, Nanomedicine and the award-winning Regenerative Medicine.

The aim of FSG is to service the advancement of clinical practice and drug research by enhancing the efficiency of communications among clinicians, researchers and decision-makers, and by providing innovative solutions to their information needs. This is achieved through a customer-centric approach, use of new technologies, products that deliver value-for-money and uncompromisingly high standards.

http://www.futuresciencegroup.com | http://www.future-medicine.com | http://www.future-science.com


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.